CDKN2D | bioCADDIE Data Discovery Index
Mountain View
biomedical and healthCAre Data Discovery Index Ecosystem
help Advanced Search
Displaying 20 of 20 results for "CDKN2D"
i
  1. Homo sapiens : CDKN2D-WDFY2 is a cancer-specific fusion gene recurrent in high-grade serous ovarian carcinoma BioProject

    ID: PRJNA280103

    Keywords: raw sequence reads

    Access Type: download

  2. Cultured human amniotic fluid-derived mesenchymal stromal cells [miRXplore data] BioProject

    ID: PRJNA155155

    Keywords: Transcriptome or Gene expression

    Access Type: download

    dataset.description: d expression of hsa-miR-125a and up-regulation of CDKN2D. The variations in TP53 and hsa-miR-125a may act as an indicator of the stemness of the hAMSC, whereas CDKN2D may indicate the reduction in the proliferative capacity of these cells in a TP53-independent mechanism. The genes described in this study will help evaluate the fitness of hAMSC, thus guaranteeing their biological quality for use in regenerative medicine. Overall design: miRNA patterns were studied in in vitro culture samples of human amniotic fluid-derived mesenchymal stromal cells at passages P1, P3, P5 and P10 with miRXplorer microarrays using a synthetic pool of miRNAs. Cell pellets of 5 x 10E5 cells were cryopreserved in liquid nitrogen and sent to Miltenyi Biotec for their analysis....
  3. Cultured human amniotic fluid-derived mesenchymal stromal cells [miRXplore data] ArrayExpress

    ID: E-GEOD-30065

    Description: d expression of hsa-miR-125a and up-regulation of CDKN2D. The variations in TP53 and hsa-miR-125a may act as an indicator of the stemness of the hAMSC, whereas CDKN2D may indicate the reduction in the proliferative capacity of these cells in a TP53-independent mechanism. The genes described in this study will help evaluate the fitness of hAMSC, thus guaranteeing their biological quality for use in regenerative medicine. miRNA patterns were studied in in vitro culture samples of human amniotic fluid-derived mesenchymal stromal cells at passages P1, P3, P5 and P10 with miRXplorer microarrays using a synthetic pool of miRNAs. Cell pellets of 5 x 10E5 cells were cryopreserved in liquid nitrogen and sent to Miltenyi Biotec for their analysis....

  4. Cultured human amniotic fluid-derived mesenchymal stromal cells [PIQOR data] ArrayExpress

    ID: E-GEOD-30064

    Description: d expression of hsa-miR-125a and up-regulation of CDKN2D. The variations in TP53 and hsa-miR-125a may act as an indicator of the stemness of the hAMSC, whereas CDKN2D may indicate the reduction in the proliferative capacity of these cells in a TP53-independent mechanism. The genes described in this study will help evaluate the fitness of hAMSC, thus guaranteeing their biological quality for use in regenerative medicine. The variations in the expression patterns of the mRNAs were studied using topic-defined PIQOR Stem Cell microarrays. Human amniotic fluid-derived mesenchymal stromal cells pellets of 5 x 10E5 cells were cryopreserved in liquid nitrogen and send to Miltenyi Biotec for their analysis. A pool of non-stimulated lymphocytes (non-mitotic cell cycle) obtained by Ficoll isolation in the Immunology Service of Carlos Haya hospital was used as a control of the expression....

  5. CDN2D_BOVIN UniProt:Swiss-Prot

    ID: Q29RV0

    Description: Cyclin-dependent kinase 4 inhibitor D ANK 1 ANK 2 ANK 3 ANK 4 N-acetylmethionine

    gene.name: CDKN2D
  6. Cultured human amniotic fluid-derived mesenchymal stromal cells [miRXplore data] OmicsDI

    ID: E-GEOD-30065

    Date Released: 05-02-2014

    Description: d expression of hsa-miR-125a and up-regulation of CDKN2D. The variations in TP53 and hsa-miR-125a may act as an indicator of the stemness of the hAMSC, whereas CDKN2D may indicate the reduction in the proliferative capacity of these cells in a TP53-independent mechanism. The genes described in this study will help evaluate the fitness of hAMSC, thus guaranteeing their biological quality for use in regenerative medicine. miRNA patterns were studied in in vitro culture samples of human amniotic fluid-derived mesenchymal stromal cells at passages P1, P3, P5 and P10 with miRXplorer microarrays using a synthetic pool of miRNAs. Cell pellets of 5 x 10E5 cells were cryopreserved in liquid nitrogen and sent to Miltenyi Biotec for their analysis....

  7. Cultured human amniotic fluid-derived mesenchymal stromal cells [PIQOR data] OmicsDI

    ID: E-GEOD-30064

    Date Released: 05-02-2014

    Description: d expression of hsa-miR-125a and up-regulation of CDKN2D. The variations in TP53 and hsa-miR-125a may act as an indicator of the stemness of the hAMSC, whereas CDKN2D may indicate the reduction in the proliferative capacity of these cells in a TP53-independent mechanism. The genes described in this study will help evaluate the fitness of hAMSC, thus guaranteeing their biological quality for use in regenerative medicine. The variations in the expression patterns of the mRNAs were studied using topic-defined PIQOR Stem Cell microarrays. Human amniotic fluid-derived mesenchymal stromal cells pellets of 5 x 10E5 cells were cryopreserved in liquid nitrogen and send to Miltenyi Biotec for their analysis. A pool of non-stimulated lymphocytes (non-mitotic cell cycle) obtained by Ficoll isolation in the Immunology Service of Carlos Haya hospital was used as a control of the expression....

  8. Cultured human amniotic fluid-derived mesenchymal stromal cells [PIQOR data] BioProject

    ID: PRJNA155153

    Keywords: Transcriptome or Gene expression

    Access Type: download

    dataset.description: d expression of hsa-miR-125a and up-regulation of CDKN2D. The variations in TP53 and hsa-miR-125a may act as an indicator of the stemness of the hAMSC, whereas CDKN2D may indicate the reduction in the proliferative capacity of these cells in a TP53-independent mechanism. The genes described in this study will help evaluate the fitness of hAMSC, thus guaranteeing their biological quality for use in regenerative medicine. Overall design: The variations in the expression patterns of the mRNAs were studied using topic-defined PIQOR Stem Cell microarrays. Human amniotic fluid-derived mesenchymal stromal cells pellets of 5 x 10E5 cells were cryopreserved in liquid nitrogen and send to Miltenyi Biotec for their analysis. A pool of non-stimulated lymphocytes (non-mitotic cell cycle) obtained by Ficoll isolation in the Immunology Service of Carlos Haya hospital was used as a control of the expression....
  9. P19-INK4D FROM MOUSE, NMR, 20 STRUCTURES PDB

    ID: PDB:1AP7

    Description: P19-INK4D

  10. CDKN2D-WDFY2 is a cancer-specific fusion gene recurrent in high-grade serous ovarian carcinoma SRA

    Accession: SRX1002876

    Organism: Homo sapiens

    Size: 6412.44

  11. CDKN2D-WDFY2 is a cancer-specific fusion gene recurrent in high-grade serous ovarian carcinoma SRA

    Accession: SRX1002920

    Organism: Homo sapiens

    Size: 1398.75

  12. CDKN2D-WDFY2 is a cancer-specific fusion gene recurrent in high-grade serous ovarian carcinoma SRA

    Accession: SRX1002894

    Organism: Homo sapiens

    Size: 6182.55

  13. CDKN2D-WDFY2 is a cancer-specific fusion gene recurrent in high-grade serous ovarian carcinoma SRA

    Accession: SRX1002872

    Organism: Homo sapiens

    Size: 6199.72

  14. CDKN2D-WDFY2 is a cancer-specific fusion gene recurrent in high-grade serous ovarian carcinoma SRA

    Accession: SRX978459

    Organism: Homo sapiens

    Size: 883.99

  15. CDKN2D-WDFY2 is a cancer-specific fusion gene recurrent in high-grade serous ovarian carcinoma SRA

    Accession: SRX1002922

    Organism: Homo sapiens

    Size: 1309.29

  16. CDKN2D-WDFY2 is a cancer-specific fusion gene recurrent in high-grade serous ovarian carcinoma SRA

    Accession: SRX1002870

    Organism: Homo sapiens

    Size: 7028.43

  17. CDKN2D-WDFY2 is a cancer-specific fusion gene recurrent in high-grade serous ovarian carcinoma SRA

    Accession: SRX976472

    Organism: Homo sapiens

    Size: 655.49

  18. CDKN2D-WDFY2 is a cancer-specific fusion gene recurrent in high-grade serous ovarian carcinoma SRA

    Accession: SRX1002921

    Organism: Homo sapiens

    Size: 1538.56

  19. CDKN2D-WDFY2 is a cancer-specific fusion gene recurrent in high-grade serous ovarian carcinoma SRA

    Accession: SRX1002918

    Organism: Homo sapiens

    Size: 15544.15

  20. CDKN2D-WDFY2 is a cancer-specific fusion gene recurrent in high-grade serous ovarian carcinoma SRA

    Accession: SRX1002849

    Organism: Homo sapiens

    Size: 1185.87


Displaying 20 of 20 results for "CDKN2D"